keyword
https://read.qxmd.com/read/38624096/endocrinological-and-metabolic-profile-of-gaucher-disease-patients-treated-with-enzyme-replacement-therapy
#21
JOURNAL ARTICLE
Ayse Kilic, Merve Emecen Sanli, Ekin Ozsaydı Aktasoglu, Sabire Gokalp, Gürsel Biberoğlu, Aslı Inci, Ilyas Okur, Fatih Suheyl Ezgu, Leyla Tumer
OBJECTIVES: Gaucher Disease (GD) is a lysosomal storage disease caused by glucocerebrosidase (GCase) enzyme deficiency. Gaucher cells transformed from the macrophages by progressive sphingolipid accumulation and infiltrate bone marrow, spleen, liver, and other organs. The accumulation of substrate causes inflammation, compromised cellular homeostasis, and disturbed autophagy. It has been hypothesized that this proinflammatory state of GD leads cytokines and chemokines release. As a result of inflammatory process, the cellular dysfunction caused by disruption of cellular signaling, organelle dysfunction, or autoimmune antibodies may affect endocrine profile of GD patients such as hormone levels, lipid profile, and bone mineral density status...
April 17, 2024: Journal of Pediatric Endocrinology & Metabolism: JPEM
https://read.qxmd.com/read/38624021/selective-degradation-of-pl2l60-by-metabolic-stresses%C3%A2-induced-autophagy-suppresses-multi%C3%A2-cancer-growth
#22
JOURNAL ARTICLE
Lei Sun, Fu Hui, Gao-Yan Tang, Hai-Lian Shen, Xue-Lei Cao, Jian-Xin Gao, Lin-Feng Li
It has been reported that PL2L60 proteins, a product of PIWIL2 gene which might be activated by an intragenic promoter, could mediate a common pathway specifically for tumorigenesis. In the present study, it was further identified by using western blot assay that the PL2L60 proteins could be degraded in cancer cells through a mechanism of selective autophagy in response to oxidative stress. The PL2L60 was downregulated in various types of cancer cells under the hypoxic condition independently of HIF‑1α, resulting in apoptosis of cancer cells...
March 2024: Oncology Reports
https://read.qxmd.com/read/38623783/conformational-and-electronic-variations-in-1-2-and-1-6-cyclophellitols-and-their-impact-on-retaining-%C3%AE-glucosidase-inhibition
#23
JOURNAL ARTICLE
Tim P Ofman, Jurriaan J A Heming, Alba Nin-Hill, Florian Küllmer, Elisha Moran, Megan Bennett, Roy Steneker, Anne-Mei Klein, Gijs Ruijgrok, Ken Kok, Zach W B Armstrong, Johannes M F G Aerts, Gijsbert A van der Marel, Carme Rovira, Gideon J Davies, Marta Artola, Jeroen D C Codée, Hermen S Overkleeft
Glycoside hydrolases (glycosidases) take part in myriad biological processes and are important therapeutic targets. Competitive and mechanism-based inhibitors are useful tools to dissect their biological role and comprise a good starting point for drug discovery. The natural product, cyclophellitol, a mechanism-based, covalent and irreversible retaining β-glucosidase inhibitor has inspired the design of diverse α- and β-glycosidase inhibitor and activity-based probe scaffolds. Here, we sought to deepen our understanding of the structural and functional requirements of cyclophellitol-type compounds for effective human α-glucosidase inhibition...
April 16, 2024: Chemistry: a European Journal
https://read.qxmd.com/read/38622591/a-ph-responsive-nanoplatform-with-dual-modality-imaging-for-enhanced-cancer-phototherapy-and-diagnosis-of-lung-metastasis
#24
JOURNAL ARTICLE
Mujie Yuan, Zeyu Han, Yan Li, Xin Zhan, Yong Sun, Bin He, Yan Liang, Kui Luo, Fan Li
To address the limitations of traditional photothermal therapy (PTT)/ photodynamic therapy (PDT) and real-time cancer metastasis detection, a pH-responsive nanoplatform (NP) with dual-modality imaging capability was rationally designed. Herein, 1 H,1 H-undecafluorohexylamine (PFC), served as both an oxygen carrier and a 19 F magnetic resonance imaging (MRI) probe, and photosensitizer indocyanine green (ICG) were grafted onto the pH-responsive peptide hexahistidine (H6 ) to form H6 -PFC-ICG (HPI). Subsequently, the heat shock protein 90 inhibitor, gambogic acid (GA), was incorporated into hyaluronic acid (HA) modified HPI (HHPI), yielding the ultimate HHPI@GA NPs...
April 15, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38622197/overcoming-braf-and-cdk4-6-inhibitor-resistance-by-inhibiting-map3k3-dependent-protection-against-yap-lysosomal-degradation
#25
JOURNAL ARTICLE
Sanghyun Park, Won-Ji Ryu, Tae Yeong Kim, Yumi Hwang, Hyun Ju Han, Jeong Dong Lee, Gun Min Kim, Joohyuk Sohn, Sang Kyum Kim, Min Hwan Kim, Joon Kim
Transcriptional programs governed by YAP play key roles in conferring resistance to various molecular-targeted anticancer agents. Strategies aimed at inhibiting YAP activity have garnered substantial interest as a means to overcome drug resistance. However, despite extensive research into the canonical Hippo-YAP pathway, few clinical agents are currently available to counteract YAP-associated drug resistance. Here, we present a novel mechanism of YAP stability regulation by MAP3K3 that is independent of Hippo kinases...
April 16, 2024: Experimental & Molecular Medicine
https://read.qxmd.com/read/38622126/ankfy1-bridges-atg2a-mediated-lipid-transfer-from-endosomes-to-phagophores
#26
JOURNAL ARTICLE
Bin Wei, Yuhui Fu, Xiuzhi Li, Fang Chen, Yiqing Zhang, Hanmo Chen, Mindan Tong, Linsen Li, Yi Pan, Shen Zhang, She Chen, Xiaoxia Liu, Qing Zhong
Macroautophagy is a process that cells engulf cytosolic materials by autophagosomes and deliver them to lysosomes for degradation. The biogenesis of autophagosomes requires ATG2 as a lipid transfer protein to transport lipids from existing membranes to phagophores. It is generally believed that endoplasmic reticulum is the main source for lipid supply of the forming autophagosomes; whether ATG2 can transfer lipids from other organelles to phagophores remains elusive. In this study, we identified a new ATG2A-binding protein, ANKFY1...
April 16, 2024: Cell Discovery
https://read.qxmd.com/read/38622059/indocyanine-green-based-nanoprobe-for-in-vivo-detection-of-cellular-senescence
#27
JOURNAL ARTICLE
Andrew G Baker, Muhamad Hartono, Hui-Ling Ou, Andrea Bistrović Popov, Emma L Brown, James Joseph, Monika Golinska, Estela González-Gualda, David Marcias, Jianfeng Ge, Mary Denholm, Samir Morsli, Chandan Sanghera, Thomas R Else, Heather F Greer, Aude Vernet, Sarah E Bohndiek, Ljiljana Fruk, Daniel Muñoz-Espín
There is an urgent need to improve conventional cancer-treatments by preventing detrimental side effects, cancer recurrence and metastases. Recent studies have shown that presence of senescent cells in tissues treated with chemo- or radiotherapy can be used to predict the effectiveness of cancer treatment. However, although the accumulation of senescent cells is one of the hallmarks of cancer, surprisingly little progress has been made in development of strategies for their detection in vivo. To address a lack of detection tools, we developed a biocompatible, injectable organic nanoprobe (NanoJagg), which is selectively taken up by senescent cells and accumulates in the lysosomes...
April 15, 2024: Angewandte Chemie
https://read.qxmd.com/read/38621338/design-synthesis-and-biological-evaluation-of-cathepsin-b-cleavage-albumin-binding-sn38-prodrug-in-breast-cancer
#28
JOURNAL ARTICLE
Yingxin Lu, Ying Huang, Jiyu Jin, Jiahui Yu, Wei Lu, Shulei Zhu
Here, we introduce a novel and effective approach utilizing a cathepsin B cleavage albumin-binding SN38 prodrug specifically designed for the treatment of metastatic breast cancer. Termed Mal-va-mac-SN38, our prodrug exhibits a unique ability to rapidly and covalently bind with endogenous albumin, resulting in the formation of HSA-va-mac-SN38. This prodrug demonstrates exceptional stability in human plasma. Importantly, HSA-va-mac-SN38 showcases an impressive enhancement in cellular uptake by 4T1 breast cancer cells, primarily facilitated through caveolin-mediated endocytosis...
April 13, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38619365/reversible-assembly-of-proteins-and-phenolic-polymers-for-intracellular-protein-delivery-with-serum-stability
#29
JOURNAL ARTICLE
Guangyu Rong, Xujiao Zhou, Jiaxu Hong, Yiyun Cheng
The design of intracellular delivery systems for protein drugs remains a challenge due to limited delivery efficacy and serum stability. Herein, we propose a reversible assembly strategy to assemble cargo proteins and phenolic polymers into stable nanoparticles for this purpose using a heterobifunctional adaptor (2-formylbenzeneboronic acid). The adaptor is easily decorated on cargo proteins via iminoboronate chemistry and further conjugates with catechol-bearing polymers to form nanoparticles via boronate diester linkages...
April 15, 2024: Nano Letters
https://read.qxmd.com/read/38618891/an-acid-responsive-dna-hydrogel-mediated-cascaded-enzymatic-nucleic-acid-amplification-system-for-the-sensitive-imaging-of-alkaline-phosphatase-in-living-cells
#30
JOURNAL ARTICLE
Shaochuan Shi, Ailing Kan, Lu Lu, Weichong Zhao, Wei Jiang
Alkaline phosphatase (ALP) is a class of hydrolase that catalyzes the dephosphorylation of phosphorylated species in biological tissues, playing an important role in many physiological and pathological processes. Sensitive imaging of ALP activity in living cells is contributory to the research on these processes. Herein, we propose an acid-responsive DNA hydrogel to deliver a cascaded enzymatic nucleic acid amplification system into cells for the sensitive imaging of intracellular ALP activity. The DNA hydrogel is formed by two kinds of Y-shaped DNA monomers and acid-responsive cytosine-rich linkers...
April 15, 2024: Analyst
https://read.qxmd.com/read/38617529/a-review-on-gaucher-disease-therapeutic-potential-of-%C3%AE-glucocerebrosidase-targeted-mrna-sarna-approach
#31
REVIEW
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, Pan Zhu, Xuehua Pan, Meilan Wei, Peng George Wang, Yang Ji, Dimitri Papukashvili
Gaucher disease (GD), a rare hereditary lysosomal storage disorder, occurs due to a deficiency in the enzyme β-glucocerebrosidase (GCase). This deficiency leads to the buildup of substrate glucosylceramide (GlcCer) in macrophages, eventually resulting in various complications. Among its three types, GD2 is particularly severe with neurological involvements. Current treatments, such as enzyme replacement therapy (ERT), are not effective for GD2 and GD3 due to their inability to cross the blood-brain barrier (BBB)...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38617351/axonal-organelle-buildup-from-loss-of-ap-4-complex-function-causes-exacerbation-of-amyloid-plaque-pathology-and-gliosis-in-alzheimer-s-disease-mouse-model
#32
Alex Orlowski, Joseph Karippaparambil, Jean-Michel Paumier, Shraddha Ghanta, Eduardo Pallares, Jamuna Tandukar, Ruixuan Gao, Swetha Gowrishankar
UNLABELLED: Lysosomes and related precursor organelles robustly build up in swollen axons that surround amyloid plaques and disrupted axonal lysosome transport has been implicated in worsening Alzheimer's pathology. Our prior studies have revealed that loss of Adaptor protein-4 (AP-4) complex function, linked primarily to Spastic Paraplegia (HSP), leads to a similar build of lysosomes in structures we term "AP-4 dystrophies". Surprisingly, these AP-4 dystrophies were also characterized by enrichment of components of APP processing machinery, β-site cleaving enzyme 1 (BACE1) and Presenilin 2...
April 1, 2024: bioRxiv
https://read.qxmd.com/read/38617306/a-mechanism-that-transduces-lysosomal-damage-signals-to-stress-granule-formation-for-cell-survival
#33
Jacob Duran, Suttinee Poolsup, Lee Allers, Monica Rosas Lemus, Qiuying Cheng, Jing Pu, Michelle Salemi, Brett Phinney, Jingyue Jia
Lysosomal damage poses a significant threat to cell survival. Our previous work has reported that lysosomal damage induces stress granule (SG) formation. However, the importance of SG formation in determining cell fate and the precise mechanisms through which lysosomal damage triggers SG formation remains unclear. Here, we show that SG formation is initiated via a novel calcium-dependent pathway and plays a protective role in promoting cell survival in response to lysosomal damage. Mechanistically, we demonstrate that during lysosomal damage, ALIX, a calcium-activated protein, transduces lysosomal damage signals by sensing calcium leakage to induce SG formation by controlling the phosphorylation of eIF2α...
April 2, 2024: bioRxiv
https://read.qxmd.com/read/38616116/sustained-release-formulation-of-hydroxypropyl-%C3%AE-cyclodextrin-eye-drops-using-xanthan-gum
#34
JOURNAL ARTICLE
Taishi Higashi, Taito Goto, Risako Onodera, Tatsunori Hirotsu, Hanako Ohashi Ikeda, Keiichi Motoyama
Bietti's crystalline dystrophy (BCD) is an autosomal recessive chorioretinal degeneration caused by mutations in the CYP4V2 gene. It is characterized by cholesterol accumulation and crystal-like deposits in the retinas. Hydroxypropyl-β-cyclodextrin (HP-β-CyD) exerts therapeutic effects against BCD by reducing lysosomal dysfunction and inhibiting cytotoxicity in induced pluripotent stem cell (iPSC)-RPE cells established from patient-derived iPS cells. However, the ocular retention of HP-β-CyD is low and needs to be improved...
2024: Chemical & Pharmaceutical Bulletin
https://read.qxmd.com/read/38615929/d-mannose-targets-pd-1-to-lysosomal-degradation-and-enhances-t-cell-mediated-anti-tumor-immunity
#35
JOURNAL ARTICLE
Wenjing Dong, Mingen Lin, Ruonan Zhang, Xue Sun, Hongchen Li, Tianshu Liu, Yanping Xu, Lei Lv
High expression of programmed cell death protein 1 (PD-1), a typical immune checkpoint, results in dysfunction of T cells in tumor microenvironment. Antibodies and inhibitors against PD-1 or its ligand (PD-L1) have been widely used in various malignant tumors. However, the mechanisms by which PD-1 is regulated are not fully understood. Here, we report a mechanism of PD-1 degradation triggered by D-mannose and the universality of this mechanism in anti-tumor immunity. We show that D-mannose inactivates GSK3β via promoting phosphorylation of GSK3β at Ser9, thereby leading to TFE3 translocation to nucleus and subsequent PD-1 proteolysis induced by enhanced lysosome biogenesis...
April 12, 2024: Cancer Letters
https://read.qxmd.com/read/38615740/urolithin-a-inhibits-breast-cancer-progression-via-activating-tfeb-mediated-mitophagy-in-tumor-macrophages
#36
JOURNAL ARTICLE
Bowen Zheng, Yuying Wang, Baian Zhou, Fengyuan Qian, Diya Liu, Danrong Ye, Xiqian Zhou, Lin Fang
INTRODUCTION: Urolithin A (UA) is a naturally occurring compound that is converted from ellagitannin-like precursors in pomegranates and nuts by intestinal flora. Previous studies have found that UA exerts tumor-suppressive effects through antitumor cell proliferation and promotion of memory T-cell expansion, but its role in tumor-associated macrophages remains unknown. OBJECTIVES: Our study aims to reveal how UA affects tumor macrophages and tumor cells to inhibit breast cancer progression...
April 12, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38615686/impaired-reprogramming-of-the-autophagy-flux-in-maturing-dendritic-cells-from-crohn-disease-patients-with-core-autophagy-gene-related-polymorphisms
#37
JOURNAL ARTICLE
Gaëlle Quiniou, Leslie Andromaque, Rémi Duclaux-Loras, Océane Dinet, Ornella Cervantes, Mallorie Verdet, Camille Meunier, Gilles Boschetti, Christophe Viret, Stéphane Nancey, Mathias Faure, Aurore Rozières
Crohn disease (CD) is an inflammatory bowel disease whose pathogenesis involves inappropriate immune responses toward gut microbiota on genetically predisposed backgrounds. Notably, CD is associated with single-nucleotide polymorphisms affecting several genes involved in macroautophagy/autophagy, the catabolic process that ensures the degradation and recycling of cytosolic components and microorganisms. In a clinical translation perspective, monitoring the autophagic activity of CD patients will require some knowledge on the intrinsic functional status of autophagy...
April 14, 2024: Autophagy
https://read.qxmd.com/read/38615685/toxic-gain-of-function-mechanisms-in-c9orf72-als-ftd-neurons-drive-autophagy-and-lysosome-dysfunction
#38
JOURNAL ARTICLE
Jimmy Beckers, Philip Van Damme
Hexanucleotide repeat expansions in the C9orf72 gene are the primary genetic cause for both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two related neurodegenerative diseases. Significant advances in the elucidation of the disease mechanisms responsible for C9orf72 ALS-FTD have revealed both a toxic gain-of-function and a loss-of-function mechanism as possible underlying disease cause. As the differential contribution of both gain and loss of function in C9orf72 ALS-FTD pathogenesis remains debated, we investigated disease mechanisms in motor neurons derived from both authentic human patient C9orf72 ALS-FTD iPSCs as well as a C9orf72 knockout iPSC line...
April 14, 2024: Autophagy
https://read.qxmd.com/read/38615082/targeting-pnpo-to-suppress-tumor-growth-via-inhibiting-autophagic-flux-and-to-reverse-paclitaxel-resistance-in-ovarian-cancer
#39
JOURNAL ARTICLE
Xin Li, Wencai Guan, Huiqiang Liu, Jia Yuan, Fanchen Wang, Bin Guan, Junyu Chen, Qi Lu, Guoxiong Xu, Lingyun Zhang
Our previous study showed that pyridoxine 5'-phosphate oxidase (PNPO) is a tissue biomarker of ovarian cancer (OC) and has a prognostic implication but detailed mechanisms remain unclear. The current study focused on PNPO-regulated lysosome/autophagy-mediated cellular processes and the potential role of PNPO in chemoresistance. We found that PNPO was overexpressed in OC cells and was a prognostic factor in OC patients. PNPO significantly promoted cell proliferation via the regulation of cyclin B1 and phosphorylated CDK1 and shortened the G2M phase in a cell cycle...
April 13, 2024: Apoptosis: An International Journal on Programmed Cell Death
https://read.qxmd.com/read/38615062/a-retrospective-study-of-morbidity-and-mortality-of-chronic-acid-sphingomyelinase-deficiency-in-germany
#40
MULTICENTER STUDY
Eugen Mengel, Nicole Muschol, Natalie Weinhold, Athanasia Ziagaki, Julia Neugebauer, Benno Antoni, Laura Langer, Maja Gasparic, Sophie Guillonneau, Marie Fournier, Fernando Laredo, Ruth Pulikottil-Jacob
BACKGROUND: Acid sphingomyelinase deficiency (ASMD) is a rare, progressive, potentially fatal lysosomal storage disease that exhibits a broad spectrum of clinical phenotypes. There is a need to expand the knowledge of disease mortality and morbidity in Germany because of limited information on survival analysis in patients with chronic ASMD (type B or type A/B). METHODS: This observational, multicentre, retrospective cohort study was conducted using medical records of patients with the first symptom onset/diagnosis of ASMD type B or type A/B between 1st January 1990 and 31st July 2021 from four German medical centres...
April 13, 2024: Orphanet Journal of Rare Diseases
keyword
keyword
35628
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.